![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Chemi S.p.a. Patrica It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Leuprorelin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2008-115 - Rev 04
This Chemical Type CEP, issued on March 10, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1442 associated with this CEP further emphasizes